DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,018,000 | -82.9% | 3,940 | -83.2% | 0.06% | -78.4% |
| Q2 2022 | $5,954,000 | +788.7% | 23,484 | +928.6% | 0.29% | +675.7% |
| Q1 2022 | $670,000 | -90.9% | 2,283 | -89.7% | 0.04% | -86.4% |
| Q4 2021 | $7,328,000 | +234.6% | 22,273 | +209.6% | 0.27% | +140.7% |
| Q3 2021 | $2,190,000 | -71.6% | 7,195 | -74.9% | 0.11% | -65.9% |
| Q2 2021 | $7,700,000 | +12.5% | 28,693 | -5.7% | 0.33% | -13.4% |
| Q1 2021 | $6,847,000 | -17.7% | 30,420 | -18.8% | 0.38% | -44.7% |
| Q4 2020 | $8,322,000 | +2218.1% | 37,461 | +2145.9% | 0.69% | +1671.8% |
| Q3 2020 | $359,000 | -19.1% | 1,668 | -33.6% | 0.04% | -47.3% |
| Q2 2020 | $444,000 | -79.7% | 2,513 | -84.1% | 0.07% | -72.1% |
| Q1 2020 | $2,184,000 | +393.0% | 15,778 | +446.1% | 0.26% | +636.1% |
| Q4 2019 | $443,000 | +121.5% | 2,889 | +108.3% | 0.04% | +200.0% |
| Q3 2019 | $200,000 | -77.6% | 1,387 | -77.8% | 0.01% | -84.4% |
| Q2 2019 | $893,000 | – | 6,249 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |